211 related articles for article (PubMed ID: 6283539)
1. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
[TBL] [Abstract][Full Text] [Related]
2. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
3. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
Thorley-Lawson DA; Schooley RT; Bhan AK; Nadler LM
Cell; 1982 Sep; 30(2):415-25. PubMed ID: 6291768
[TBL] [Abstract][Full Text] [Related]
5. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
[TBL] [Abstract][Full Text] [Related]
9. Regulation of antibody production by an antigen-specific EBV-transformed B-lymphoblastoid cell line: effect of high-dose antigen and antigen-pulsed T cells.
McCaughan GW; Brown MH; Callard RE
Immunology; 1986 Aug; 58(4):597-602. PubMed ID: 3015782
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
Rowe M; Hildreth JE; Rickinson AB; Epstein MA
Int J Cancer; 1982 Apr; 29(4):373-81. PubMed ID: 6282762
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
12. Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas.
Lakow ES; Valentine MA; Vaughan JH; Tsoukas CD; Carson DA
Cell Immunol; 1984 Apr; 85(1):67-74. PubMed ID: 6325024
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus (EBV) alters the B cell glycolipid which is recognized by the human monoclonal antibody to i-blood group antigen.
Nagatsuka Y; Yamaki M; Watarai S; Yasuda T; Higashi H; Yamagata T; Ono Y
Virus Res; 1996 Jul; 43(1):57-68. PubMed ID: 8822634
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro.
Kotsiopriftis M; Tanner JE; Alfieri C
J Virol; 2005 Jun; 79(11):7255-61. PubMed ID: 15890964
[TBL] [Abstract][Full Text] [Related]
15. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
Rosenthal KS; Shuman H; Strominger JL
J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
[No Abstract] [Full Text] [Related]
16. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
17. Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies.
Hearing JC; Lewis A; Levine AJ
Virology; 1985 Apr; 142(1):215-20. PubMed ID: 2997981
[TBL] [Abstract][Full Text] [Related]
18. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
[TBL] [Abstract][Full Text] [Related]
19. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
Ling NR; Lowe JA
Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
[TBL] [Abstract][Full Text] [Related]
20. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.
Jondal M; Klein G
J Exp Med; 1973 Dec; 138(6):1365-78. PubMed ID: 4357682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
